Description
The main objective of the Action is to promote research on and use of small fish as models for human diseases via the establishment of a communication platform. This COST Action will coordinate the distribution of these fish models and will disseminate contacts and knowledge to investigate the molecular and genetic basis of the disturbed physiology of these models. The main audience will be the wider biomedical research community and industry for a faster translation of research into medical applications and as in vivo systems for drug development and toxicity testing.
Action keywords
Zebrafish - medaka - human disease models - drug screening - toxicology
Parties
Action Leadership Positions
Role | Leader |
---|---|
Action Chair | |
Action Vice-Chair |
Management Committee
Country | MC Member |
---|---|
Austria | |
Belgium | |
Belgium | |
Denmark | |
Denmark | |
Denmark | |
Finland | |
Finland | |
France | |
France | |
Germany | |
Greece | |
Greece | |
Hungary | |
Iceland | |
Iceland | |
Ireland | |
Ireland | |
Israel | |
Israel | |
Italy | |
Italy | |
Netherlands | |
Netherlands | |
Norway | |
Norway | |
Portugal | |
Spain | |
Spain | |
Sweden | |
Sweden | |
Switzerland | |
Switzerland | |
Switzerland | |
United Kingdom | |
United Kingdom |
Country | MC Substitute |
---|---|
Finland | |
Germany | |
Germany | |
Ireland | |
Spain | |
Spain | |
Switzerland | |
United Kingdom | |
United Kingdom | |
United Kingdom | |
United Kingdom |
COST International Partner Countries
Institution Name | MC Observer |
---|---|
The University of Auckland | |
Australian Regenerative Medicine Institute |